Aun Consulting
2459
DMS
9782
Wellco Holdings
7831
Metaplanet
3350
Perseus Proteomics
4882
JP Stock MarketDetailed Quotes
197A Tauns Laboratories
- 512
- -3-0.58%
20min DelayMarket Closed Mar 21 15:30 JST
52.37BMarket Cap9.48P/E (Static)
516High510Low458.30KVolume513Open515Pre Close235.12MTurnover73352wk High1.97%Turnover Ratio102.29MShares40152wk Low53.99EPS TTM11.90BFloat Cap733Historical High9.48P/E (Static)23.25MShs Float401Historical Low53.99EPS LYR1.17%Amplitude11.00Dividend TTM3.21P/B100Lot Size2.08%Div YieldTTM
Tauns Laboratories News
Tauns Laboratories: Financial Highlights for 2Q ended December 31, 2024
Tauns Laboratories: Interim financial results presentation materials for the fiscal year ending 2025/6
Tauns Laboratories: Financial Results for the SIX Months Ended December 31, 2024 (Japanese Accounting Standards)
Tauns Laboratories: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/6 [Japanese GAAP] (unconsolidated)
Tauns Laboratories: Half Year Report - Term 10 (2024/07/01 - 2025/06/30)
Tauns Laboratories: Confirmation
Tauns Laboratories: Notice of Strategic Business Alliance with ZACROS Corporation
Tauns Laboratories: Announcement of a strategic business alliance with ZACROS Co., Ltd.
Tauns Laboratories: Patent on Method and Reagent for Detecting Target Substance Granted in Japan
Tauns Laboratories: Notice of patent acquisition relating to target substance detection methods and reagents
Tauns Laboratories: (Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
Tauns Laboratories: (Progress of disclosure matters) Notice of conclusion of a basic transaction agreement with Roche Diagnostics Co., Ltd.
Tauns Laboratories: Correction report (Large shareholding report / Change report)
Tauns Laboratories: Notice concerning Memorandum of Understanding to enter into Master Transaction Agreement between TAUNS Laboratories, Inc. and Roche Diagnostics K.K.
Tauns Laboratories: Notice of conclusion of a basic agreement on the basic transaction agreement between Towns and Roche Diagnostics
Tauns Laboratories: change report
Tauns Laboratories: Change report.
Tauns Laboratories: Notice regarding Preparation for Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
Tauns Laboratories: Notice regarding preparations for applying for a change in market classification to the Tokyo Stock Exchange Prime Market
Tauns Laboratories: Summary of financial results for the 1st quarter of the fiscal year ending 2025/6 [Japanese GAAP] (unconsolidated)